Form 4: Lucid Group Director Andrew Liveris Reports Acquisition of Over 113,000 Restricted Stock Units
Insider Transaction Report
Lucid Group, Inc. Director Andrew N. Liveris has reported the acquisition of 113,544 Class A Common Stock through restricted stock unit grants, increasing his direct beneficial ownership to 798,930 shares.
Summary
- Andrew N. Liveris, a Director of Lucid Group, Inc. (LCID), acquired a total of 113,544 shares of Class A Common Stock through Restricted Stock Unit (RSU) grants on June 5, 2025.
- One grant involved 108,713 RSUs, which will vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, contingent on his continued service on the board. Shares will be issued upon a designated deferred settlement date.
- A second grant involved 4,831 RSUs, which vested in full on the date of the grant in connection with past service.
- Following these transactions, Mr. Liveris's direct beneficial ownership of Class A Common Stock increased to 798,930 shares.
- Additionally, 400,000 shares of Common Stock are held indirectly by Liveris Capital Partners LLC, though Mr. Liveris disclaims beneficial ownership of these shares. These shares were part of a distribution in January 2023.
Sentiment
Score: 7
Explanation: The RSU grants are a positive sign of continued director commitment and alignment with shareholder interests, which is generally viewed favorably. There are no negative operational or financial details in this filing.
Positives
- The grant of Restricted Stock Units (RSUs) to Director Andrew N. Liveris aligns his interests with those of shareholders, incentivizing long-term performance and retention.
- The vesting schedule for the 108,713 RSUs encourages continued service on the board of directors.
Negatives
- The RSU grants, while common compensation, represent a potential future dilution of existing shareholder equity upon conversion to common stock.
Risks
- No specific risks related to company operations or financial health are detailed in this Form 4 filing. The primary risk associated with RSU grants is potential future dilution of existing shares upon conversion.
Future Outlook
The vesting schedule for a portion of the granted RSUs indicates a future commitment of the reporting person to continued service on the board of directors, aligning with the company's long-term governance and strategic objectives.
Industry Context
This Form 4 filing reflects a standard practice in corporate governance where publicly traded companies grant equity awards, such as Restricted Stock Units (RSUs), to their directors as a form of compensation and to align their interests with long-term shareholder value. Such grants are common across the automotive and technology sectors, particularly for companies like Lucid Group that are in growth phases and rely on attracting and retaining experienced leadership.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Andrew Liveris granted a Power of Attorney to Gagan Dhingra, Brian Tomkiel, Doug Stewart, and Bruce Wang to execute and file SEC Forms 3, 4, 5, and 144 on his behalf, streamlining compliance with Section 16(a) of the Exchange Act and the Securities Act. | 2025-05-31 | Enhances efficiency and ensures timely compliance with SEC reporting requirements for insider transactions. |
Related Party Transactions
- 400,000 shares of Common Stock are held indirectly by Liveris Capital Partners LLC. Mr. Liveris disclaims beneficial ownership of these shares, which were received as part of a distribution from Churchill Sponsor IV LLC in January 2023.
Stakeholder Impact
- Shareholders: The RSU grants align the director's interests with shareholders, potentially leading to better long-term decision-making. However, they also represent a future dilutive event when the RSUs convert to common stock.
- Management: The RSU grants serve as a retention and incentive mechanism for the director.
Next Steps
- Vesting of 108,713 RSUs on the earlier of the one-year anniversary of the grant date (June 5, 2026) or the date of the next annual meeting of stockholders held after the grant date, subject to continued service.
- Issuance of shares for the 108,713 RSUs upon the designated deferred settlement date.
Key Dates
| Date | Description |
|---|---|
| 2023-01-01 | Approximate date when Liveris Capital Partners LLC received 400,000 shares of Common Stock as part of a distribution from Churchill Sponsor IV LLC. |
| 2025-05-31 | Date Andrew Liveris executed the Power of Attorney for SEC filings. |
| 2025-06-05 | Date of RSU grants to Andrew N. Liveris. |
| 2025-06-09 | Date the Form 4 was signed by Andrew N. Liveris's attorney-in-fact. |
Keywords
Lucid Group, LCID, Andrew Liveris, Form 4, SEC filing, Restricted Stock Units, RSU, insider transaction, beneficial ownership, director compensation, equity grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.